Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision Therapy for the Treatment of Primary Immunodysregulatory Diseases.

Immunology and allergy clinics of North America - 1 Aug 2020

Chellapandian Deepak, Chitty-Lopez Maria, Leiding Jennifer W

Abstract excerpt

Precision therapy is a concept in which medical treatment is tailored to the patient's individual needs based on individual characteristics and mechanism of disease. Primary immunodysregulatory disorders are an expanding group of primary immunodeficiency diseases that are characterized by early onset autoimmunity and autoinflammation. Precision therapy allows for the alteration of the aberrant immune response...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diagnosis, Differential
Share to Disease Management
Share to Disease Susceptibility

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gain of Function Mutation

Share to Haploinsufficiency

Share to Immunologic Deficiency Syndromes

Share to Molecular Targeted Therapy

Share to Precision Medicine

Source

Identifiers

PMID: 32654696
DOI: 10.1016/j.iac.2020.04.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision Therapy for the Treatment of Primary Immunodysregulatory Diseases.PMID 32654696Read ↗

Precision medicine: The use of tailored therapy in primary immunodeficiencies.Semantic proximity Read ↗

Targeted strategies directed at the molecular defect: Toward precision medicine for select primary immunodeficiency disorders.Semantic proximity Read ↗

PRECISION THERAPEUTICS IN PRIMARY IMMUNE REGULATORY DISORDERS: CURRENT ADVANCES AND FUTURE DIRECTIONSSemantic proximity Read ↗

PRECISION THERAPEUTICS IN PRIMARY IMMUNE REGULATORY DISORDERS: CURRENT ADVANCES AND FUTURE DIRECTIONSSemantic proximity Read ↗

Targeted treatment of autoimmune cytopenias in primary immunodeficiencies.Semantic proximity Read ↗

Immunodeficiency and disorders of immune dysregulation.Semantic proximity Read ↗

Precision Medicine in the Treatment of Primary Immune Deficiency Patients With Disorders of Immune Dysregulation.Semantic proximity Read ↗

Modern management of primary T-cell immunodeficiencies.Semantic proximity Read ↗

Type I interferonopathies—an expanding disease spectrum of immunodysregulationSemantic proximity Read ↗

Precision medicine in autoimmune diseases: fact or fictionSemantic proximity Read ↗

Primary Immune Regulatory Disorders and Targeted TherapiesSemantic proximity Read ↗

Exploring precision treatments in immune‐mediated inflammatory diseases: Harnessing the infinite potential of nucleic acid deliverySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.